BNP Paribas Asset Management (BNPP AM) has launched ESG-filtered thematic ETFs targeting medical technology and the hydrogen economy.
The BNP Paribas Easy ECPI Global ESG Med Tech UCITS ETF and BNP Paribas Easy ECPI Global Hydrogen Economy UCITS ETF are listed on the Deutsche Boerse and Euronext Paris with total expense ratios (TERs) of 0.30%.
BNPP AM’s med tech ETF replicates the ECPI Global ESG Medical Tech index, which equally weights the 50 “most active” stocks within biotechnology, life sciences tools and services, healthcare equipment and suppliers and healthcare technology.
The product also applies environmental, social and governance (ESG) screens and sector exclusions on the medical tech investment universe. It is classified under Article 8 of the Sustainable Finance Disclosure Regulation (SFDR).
The hydrogen economy ETF tracks the ECPI Global ESG Hydrogen Economy index of 40 companies involved in the production, supply and storage of green hydrogen and those producing renewable energy used in sustainable hydrogen production.
Constituents are also selected based on their performance on ESG criteria and their efforts to reduce their exposure to coal and unconventional fossil fuels. The ETF is classified under Article 9 of the SFDR.
Commenting on the launches, Denis Panel, head of multi-asset, quantitative and solutions at BNPP AM, said: “The healthcare and green hydrogen sectors are enjoying strong growth and are themes of the future, enabling us to offer relevant long-term investment solutions.
“These two launches expand our range of index funds and demonstrate our desire to be a key provider of thematic ESG ETFs.”
BNPP has been active elsewhere in ESG in recent months. In December, the firm overhauled its €9bn ETF range onto ESG and Paris-Aligned indices.